Icahn Asks Holders of ImClone Shares to Oust 6 on Board
498008
Investor Carl C. Icahn will not seek to remove the six board members unless shareholders approve one of his own nominees.
568863
BEA Systems replied Monday to investor Carl Icahn&#39;s demand for a shareholder vote on purchase bids for the company.
768370
Billionaire investor Carl Icahn yesterday offered to purchase Mylan Laboratories for $20 per share, part of his plan to derail the Canonsburg generic drug maker&#39;s proposed acquisition of King Pharmaceuticals.
454466
IntercontinentalExchange Inc.  on Thursday urged CBOT Holdings Inc.  shareholders and members to reject the proposed sale of the company to Chicago Mercantile Exchange Holdings Inc. .
664157
Financier Carl Icahn on Friday offered to buy the shares of generic drugmaker Mylan Laboratories that he does not already own for $4.9 billion, or $20 a share, according to a government filing.
260832
BOSTON  â The investor Carl C. Icahn said on Monday that he was trying to get three supporters elected to the board of the biotechnology firm Biogen Idec because of concerns over the sales process.
77810
Billionaire investor Carl Icahn said on Friday a sale of BEA Systems Inc.  to a strategic acquirer would maximize the value of its shares and that he might seek to nominate directors to the software maker's board.
647205
Investor Carl Icahn on Friday said he  has no plans to raise his $36-per-share offer for auto parts  maker Lear Corp. , saying the price is &quot;fair.&quot;
626345
Mylan Laboratories Inc.&#39;s (MYL.N: Quote, Profile, Research) board on Monday rebuffed financier Carl Icahn&#39;s bid to buy the company, and said it remains committed to
326818
Financier Carl Icahn on Monday said King Pharmaceutical Inc.&#39;s (KG) possible need to restate earnings reinforces his belief that an acquisition of King by Mylan Laboratories Inc.
15173
Reckson Associates Realty Corp.  said on Monday it would postpone a shareholder meeting until December 6 to give billionaire Carl Icahn and his partners more time to firm up financing for their $4.6 billion bid for the company.
121287
The investor Carl C. Icahn said he was trying to get three supporters elected to the board of the biotechnology firm Biogen Idec because of concerns over the sales process.
610572
SAN FRANCISCO, Oct. 29 -- After shooing away Oracle's $6.7 billion takeover bid, BEA Systems dug in its heels for a potentially disruptive battle with its largest shareholder, activist investor Carl C. Icahn.
105149
By MIKE CRISSEY, Associated Press Writer, The Associated Press. Icahn, one of the 1980s most prolific corporate raiders, bought 18.
473616
Billionaire investor Carl Icahn cut  his stake in media company Time Warner Inc. to 20 million  shares in the fourth quarter from 55 million shares, according  to a U.S. regulatory filing on Wednesday.
270801
NEW YORK/BOSTON  - Billionaire investor Carl Icahn said on Tuesday he will seek a seat on Motorola Inc.'s  board and has taken a stake in the mobile phone maker, aiming to convince it to do a big share buyback.
472316
BEA Systems&#39; largest shareholder is demanding that its board of directors allow shareholders to vote on a&#160;$17-per-share purchase offer from Oracle, which is set to expire at 5 p.m. Pacific Time Sunday.Carl Icahn, who holds more than 58 million shares of BEA stock, said in a statement that he has begun lawsuit proceedings in Delaware to force an annual shareholder meeting &quot;before any scorched earth transactions (such as stock issuances, asset sales, acquisitions or similar occurrences) take place at BEA, other than transactions that are approved by shareholders.&quot;The investor accused BEA&#39;s board of intending &quot;to find ways to derail a sale and maintain your control of the company.&quot;&#160;BEA&#39;s board has repeatedly rejected Oracle&#39;s bid&#160;to buy the company,&#160;demanding $21 per share. Oracle&#39;s offer amounts to $6.7 billion, while BEA&#39;s demand works out to $8.3 billion. Oracle has called that price &quot;impossibly high.&quot;Icahn said BEA can avoid litigation if it conducts an auction sale, allowing shareholders to consider offers from the highest bidder.&quot;BEA should not allow the stalking horse bid from Oracle to disappear (failure to take the Oracle bid as a stalking horse would be a grave dereliction of your fiduciary duty in my view),&quot; he wrote. &quot;But if no topping bid arises it should be up to the BEA shareholders to decide whether to take the Oracle bid or remain as an independent Company.&quot;Icahn also demanded that &quot;BEA should agree not to take any action that would dilute voting by issuing stock, entrench management or derail a potential sale of BEA.&quot;Shares of BEA stock closed at $16.50 and were trading at $16.75 after hours on Friday.A BEA spokesman could not immediately be reached for comment.